Top 10 stocks for today – 13th July, 2023

13 Jul 2023 , 07:53 AM

Here are some stocks that may show significant price movement today.

1. TCS: Technology major TCS (Tata Consultancy Services) has announced its financial results for the June quarter, revealing a substantial year-on-year (YoY) increase in consolidated net profit. The company reported a nearly 17% rise, reaching Rs 11,074 crore.
2. HCL Tech: The company has reported disappointing results for the June quarter, with a significant miss on revenue and margin. The constant currency revenue slipped to 1.3%, indicating a decline in revenue growth for the second consecutive quarter when measured in constant currency terms.
3. Deep Industries: The company has been granted a letter of award (LoA) by ONGC (Oil and Natural Gas Corporation) for a project valued at Rs 130 crore. This LoA signifies that the company has been selected by ONGC to undertake and execute the specified project.
4. Patanjali Foods: The company has announced the launch of an Offer for Sale (OFS) in which it plans to sell up to 7 percent of its equity. The floor price for the OFS has been set at Rs 1,000 per share, representing an 18 percent discount to the closing price of the shares on Wednesday.
5. Hindalco Industries: On Wednesday, Aditya Birla Group’s metals flagship announced the sale of Kalwa land to Birla Estates Pvt. Ltd. for a total amount of Rs 595 crore. The transaction will involve the payment of the consideration in multiple tranches over a specified period.
6. Lupin: Lupin, a pharmaceutical company, announced that the US Food and Drug Administration (FDA) has conducted an inspection of its Nagpur oral solid dosage facility. The inspection took place from July 3 to July 11, 2023, and as a result, the FDA has issued a Form-483 with two observations.
7. SpiceJet: Ajay Singh, the Chairman and Managing Director of SpiceJet, has announced his plans to invest Rs 500 crore into the airline. This investment will be made through subscribing to fresh equity shares and convertible instruments.
8. Aurobindo Pharma: APL Healthcare has received approval from the US Food and Drug Administration (FDA) for its generic version of Renagel, known as Sevelamer Hydrochloride. Renagel is a medication prescribed to patients undergoing dialysis to help reduce elevated levels of phosphorus in the blood.
9. Dr Reddy’s: Dr. Reddy’s Laboratories has had its proposed biosimilar application for Rituximab accepted by the US Food and Drug Administration (FDA) for review. Rituximab is a medication utilized in the treatment of arthritis, lymphoma, and leukemia.
10. Wipro: The company will announce its first quarter results today.